About HS Code 300120
This category encompasses a specialized segment of the pharmaceutical trade, dealing with biological materials derived from animal or human glands and organs, specifically prepared for therapeutic applications. These extracts are crucial for developing treatments for various medical conditions, often involving hormone replacement or enzyme deficiencies. Importers are typically pharmaceutical manufacturers, research institutions, and specialized clinics, while exporters are often countries with robust biotechnology sectors and access to raw biological materials, such as those with significant livestock industries or advanced medical waste processing capabilities. Key considerations in this trade include stringent regulatory oversight, cold chain logistics, ethical sourcing of biological materials, and the high value associated with these highly processed and purified substances. The global market for these products is driven by advancements in biotechnology and an aging population requiring sophisticated medical interventions.
Products Under This Code
Pancreatic extracts, Thyroid extracts, Adrenal cortex extracts, Pituitary gland extracts, Ovarian extracts, Liver extracts for therapy, Thymus extracts
Real World Examples
Pancreatin (e.g., Creon), Thyroid USP (e.g., Armour Thyroid), Adrenocorticotropic hormone (ACTH) preparations, Heparin (active ingredient, historically from animal organs), Insulin (historically from animal pancreas)
Common Misclassification
This code can be confused with 300190 if the extracts are not specifically for "organo-therapeutic uses" or with 3004 (medicaments) if they are already formulated into finished dosage forms.
Products Classified Under 3001.20
Industry
This code belongs to the Chemicals industry.
Trade Overview
Major players in this trade include countries with advanced pharmaceutical industries like Germany, Switzerland, and the USA, as well as those with significant animal processing industries.
Frequently Asked Questions
What is HS code 300120?
HS code 300120 covers: Glands and other organs; extracts of glands or other organs or of their secretions, for organo-therapeutic uses. This category encompasses a specialized segment of the pharmaceutical trade, dealing with biological materials derived from animal or human glands and organs, specifically prepared for therapeutic applications. These extracts are crucial for developing treatments for various medical conditions, often involving hormone replacement or enzyme deficiencies. Importers are typically pharmaceutical manufacturers, research institutions, and specialized clinics, while exporters are often countries with robust biotechnology sectors and access to raw biological materials, such as those with significant livestock industries or advanced medical waste processing capabilities. Key considerations in this trade include stringent regulatory oversight, cold chain logistics, ethical sourcing of biological materials, and the high value associated with these highly processed and purified substances. The global market for these products is driven by advancements in biotechnology and an aging population requiring sophisticated medical interventions.
What products fall under HS code 300120?
Pancreatic extracts, Thyroid extracts, Adrenal cortex extracts, Pituitary gland extracts, Ovarian extracts, Liver extracts for therapy, Thymus extracts
What are common misclassifications for HS code 300120?
This code can be confused with 300190 if the extracts are not specifically for "organo-therapeutic uses" or with 3004 (medicaments) if they are already formulated into finished dosage forms.
How is HS code 300120 structured?
HS code 300120 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (01) identify the heading, and digits 5-6 (20) specify the subheading. This code is standardized globally by the World Customs Organization.